Person:
Wong, Janice C.

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Wong

First Name

Janice C.

Name

Wong, Janice C.
Author's Publications: search.filters.isAuthorOfPublication.ece11c16-655c-4bf0-84c5-e6f4b7ea8e97

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    Publication
    Myelodysplastic syndrome with progressive multifocal predominantly pontine demyelination
    (Lippincott Williams & Wilkins, 2015) Bhattacharyya, Shamik; Wong, Janice C.; Abedalthagafi, Malak; Wahlster, Sarah; Vaitkevicius, Henrikas
  • Thumbnail Image
    Publication
    Involvement of low- and middle-income countries in randomized controlled trial publications in oncology
    (BioMed Central, 2014) Wong, Janice C.; Fernandes, Kimberly A; Amin, Shubarna; Lwin, Zarnie; Krzyzanowska, Monika K
    Background: We describe trends in participation by investigators from low- and middle-income countries (LMCs) in publications describing oncology randomized control trials (RCTs) over a decade. Methods: We used Medline to identify RCTs published in English from 1998 to 2008 evaluating treatment in lung, breast, colorectal, stomach and liver cancers. Data on author affiliations, authorship roles, trial characteristics, funding and interventions were extracted from each article. Countries were stratified as low-, middle- or high-income using World Bank data. Interventions were categorized as requiring basic, limited, enhanced or maximal resources as per the Breast Health Global Initiative classification. Logistic regression was used to identify factors associated with authorship by investigators from LMCs. Results: 454 publications were identified. Proportion of articles with at least one LMC author increased over time from 20% in 1998 to 29% in 2008 (p = 0.01), but almost all LMC authors were from middle-income countries. Proportion of articles with at least one LMC author was higher among articles that explicitly reported recruitment in at least one LMC vs those that did not (76% vs 13%). Among 87 articles (19%) that involved authors from LMCs, 17% had LMC authors as first or corresponding authors, and 67% evaluated interventions requiring enhanced or maximal resources. Factors associated with LMC authorship included industry funding (OR = 3.54, p = 0.0001), placebo comparator arm (OR = 2.57, p = 0.02) and palliative intent treatment (OR = 4.00, p = 0.0003). Conclusion: An increasing number of publications describing oncology RCTs involve authors from LMC countries but primarily in non-leadership roles in industry-funded trials.
  • Thumbnail Image
    Publication
    Actin polymerization stabilizes α4β1 integrin anchors that mediate monocyte adhesion
    (The Rockefeller University Press, 2012) Rullo, Jacob; Becker, Henry; Hyduk, Sharon J.; Wong, Janice C.; Digby, Genevieve; Arora, Pamma D.; Cano, Adrianet Puig; Hartwig, John; McCulloch, Christopher A.; Cybulsky, Myron I.
    Leukocytes arrested on inflamed endothelium via integrins are subjected to force imparted by flowing blood. How leukocytes respond to this force and resist detachment is poorly understood. Live-cell imaging with Lifeact-transfected U937 cells revealed that force triggers actin polymerization at upstream α4β1 integrin adhesion sites and the adjacent cortical cytoskeleton. Scanning electron microscopy revealed that this culminates in the formation of structures that anchor monocyte adhesion. Inhibition of actin polymerization resulted in cell deformation, displacement, and detachment. Transfection of dominant-negative constructs and inhibition of function or expression revealed key signaling steps required for upstream actin polymerization and adhesion stabilization. These included activation of Rap1, phosphoinositide 3-kinase γ isoform, and Rac but not Cdc42. Thus, rapid signaling and structural adaptations enable leukocytes to stabilize adhesion and resist detachment forces.